Media ReleaseEliminate Cancer15 May 2019

$5 million donation to Zero Childhood Cancer to help kids like Jack beat brain cancer

Minderoo Foundation’s Eliminate Cancer initiative has announced a $5 million partnership with the Zero Childhood Cancer program to help fast track children with high-risk aggressive cancers into treatment with new drugs specifically tailored for their disease.

photo-jack
Jack Burai was diagnosed with an aggressive brain tumour in 2017 at 10 years old.

Two years ago, Jack Burai was diagnosed with a low-grade cancer in the brain (glioma) at just 9 years old. Following surgery his prognosis was good and his parents, Vivian and Alex believed Jack to be cured. 12 months later Jack relapsed and was in hospital with multiple tumours in his brain and spine, his cancer failed to respond to standard treatment and his condition was rapidly declining.  His eyesight was threatened by the build-up of fluid in his brain and he could no longer walk.

Jack was enrolled in the Zero Childhood Cancer program (Zero), which genetically tested Jack’s cancer, and detected a BRAF V600E mutation that was believed to be driving the aggressive growth of his cancer.  The team identified new therapies uniquely designed to target and kill his tumours. Within 45 days Jack was out of a wheelchair, playing tennis, and doctors believe it’s likely Jack is cured.

Today (15 May) Minderoo Foundation’s Eliminate Cancer initiative will announce a $5 million partnership with Zero to help scale the program in Australia, drive further research into personalised medicine in childhood cancer and help established standardised international protocols.

Australian philanthropists Andrew and Nicola Forrest founded Minderoo Foundation in 2001 and, since then, have committed over $1.5 billion to the Foundation and its partners to address some of the world’s most urgent and complex challenges, including the fight against cancer which Minderoo has committed $75 million to through its Eliminate Cancer initiative.

“The vision of the Zero Childhood Cancer program is simple and inspiring: reduce child cancer deaths to Zero,” Mr Forrest said.

“Cancer has no right to strip children of their bright futures and must be arrested through collaboration and world-class research here in Australia, and around the world. As adults we have the duty to protect and improve the lives of these children and Minderoo is proud to partner with Zero to help realise this.”

May is International Brain Cancer Awareness Month which aims to highlight the fact that more children die from brain cancer than any other cancer.

The challenge in curing children with cancer is that each child and each cancer is unique meaning standard therapies are not effective for every child.

Zero, led in partnership by Children’s Cancer Institute and Kids Cancer Centre at Sydney Children’s Hospital, Randwick, is designed to fast track children with high-risk aggressive cancers into treatment with new drugs specifically tailored for their unique disease. 

02-09-18_127

Professor Michelle Haber AM, Executive Director Children’s Cancer Institute, A/Professor Tracey O’Brien, Director Kids Cancer Centre, Sydney Children’s Hospital, Randwick, Mina and Rob with their daughter Ellie.

As with Jack, once accepted into Zero’s national clinical trial, the child’s cancer cells undergo extensive and sophisticated genetic testing and analysis. In parallel, when possible, their tumour cells are subjected to detailed laboratory analyses to determine their response to a range of anti-cancer drugs. This combined approach helps to identify the treatments most likely to target and kill each child’s specific cancer and give them the greatest possible chance of survival.

The Zero Childhood Cancer Program which has built a collaborative network of 21 national and international research partners opened a national clinical trial in September 2017 at all eight children’s hospitals in Australia. In the first 20 months of the trial more than 200 children have been enrolled, with personalised treatments recommendations made for more than 70% of the children and reported to the children’s treating doctors within an average of 9 weeks.

More than 400 children are expected to be enrolled in the national trial by September 2020, according to Professor Michelle Haber AM, Executive Director of Children’s Cancer Institute, with a third of all the patients involved in the program being children with aggressive brain cancer. “Stories like Jack’s, and others, show that Zero Childhood Cancer can provide exciting new options where standard treatments have failed. For the first time we have a real chance to defeat aggressive childhood cancers, and it’s donations like the one today from Andrew and Nicola Forrest’s Minderoo Foundation that can make this happen,” she said.

A/Professor Tracey O’Brien, Director of Kids Cancer Centre, Sydney Children’s Hospital, Randwick, explained “three children are dying from cancer in Australia every week. Zero Childhood Cancer aims to change this, by unlocking each individual child’s cancer and then targeting the therapy to achieve better results. It’s about giving the right drug to the right child at the right time. Jack’s story demonstrates what can be achieved with this approach, it is tomorrow’s care today.”

Vivian Rosati, Jack’s mum said she is “beyond grateful” to the program. “We would like to thank everyone for allowing our son to enter the Zero program which has changed our lives and saved his. Donations like this today means that other families will have the same chance, programs like Zero Childhood Cancer give families hope where there would otherwise be none,” she said. 

Minderoo Foundation
by Minderoo Foundation
Established by Andrew and Nicola Forrest in 2001, we are a modern philanthropic organisation seeking to break down barriers, innovate and drive positive, lasting change. Minderoo Foundation is proudly Australian, with seven key initiatives spanning from ocean research and ending slavery, to collaboration in cancer and community projects.
4 minute read
Share this article
Other Stories